Dave Trong Nguyen

Array ( [id] => 1391982 [patent_doc_number] => 06544955 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Method of sensitizing tumor cells with adenovirus E1A' [patent_app_type] => B1 [patent_app_number] => 09/510885 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 6241 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544955.pdf [firstpage_image] =>[orig_patent_app_number] => 09510885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1323674 [patent_doc_number] => 06602706 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Packaging systems for human recombinant adenovirus to be used in gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/506548 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 28 [patent_no_of_words] => 18006 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602706.pdf [firstpage_image] =>[orig_patent_app_number] => 09506548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1544899 [patent_doc_number] => 06444463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cells' [patent_app_type] => B1 [patent_app_number] => 09/499227 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30786 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444463.pdf [firstpage_image] =>[orig_patent_app_number] => 09499227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543026 [patent_doc_number] => 06372722 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Method for nucleic acid transfection of cells' [patent_app_type] => B1 [patent_app_number] => 09/487089 [patent_app_country] => US [patent_app_date] => 2000-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17503 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372722.pdf [firstpage_image] =>[orig_patent_app_number] => 09487089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612758 [patent_doc_number] => 06903077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Methods and products for delivering nucleic acids' [patent_app_type] => utility [patent_app_number] => 09/477391 [patent_app_country] => US [patent_app_date] => 2000-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31986 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903077.pdf [firstpage_image] =>[orig_patent_app_number] => 09477391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1461584 [patent_doc_number] => 06350444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase' [patent_app_type] => B1 [patent_app_number] => 09/470007 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9334 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350444.pdf [firstpage_image] =>[orig_patent_app_number] => 09470007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420657 [patent_doc_number] => 06518480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand' [patent_app_type] => B1 [patent_app_number] => 09/341446 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 25519 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518480.pdf [firstpage_image] =>[orig_patent_app_number] => 09341446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404652 [patent_doc_number] => 06264990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity.' [patent_app_type] => 1 [patent_app_number] => 9/269685 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7966 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264990.pdf [firstpage_image] =>[orig_patent_app_number] => 269685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425167 [patent_doc_number] => 06503886 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Compositions containing nucleic acids and ligands for therapeutic treatment' [patent_app_type] => B1 [patent_app_number] => 09/449249 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 41 [patent_no_of_words] => 71981 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503886.pdf [firstpage_image] =>[orig_patent_app_number] => 09449249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631318 [patent_doc_number] => 06635614 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol' [patent_app_type] => B1 [patent_app_number] => 09/068386 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 11148 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635614.pdf [firstpage_image] =>[orig_patent_app_number] => 09068386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565326 [patent_doc_number] => 06339070 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety' [patent_app_type] => B1 [patent_app_number] => 09/423439 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 34485 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339070.pdf [firstpage_image] =>[orig_patent_app_number] => 09423439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1412209 [patent_doc_number] => 06511676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes' [patent_app_type] => B1 [patent_app_number] => 09/434345 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13881 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511676.pdf [firstpage_image] =>[orig_patent_app_number] => 09434345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1574454 [patent_doc_number] => 06468793 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'CFTR genes and proteins for cystic fibrosis gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/425453 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29066 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468793.pdf [firstpage_image] =>[orig_patent_app_number] => 09425453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533719 [patent_doc_number] => 06410693 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Inhibitors of the JNK signal transduction pathway and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/419587 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 17939 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410693.pdf [firstpage_image] =>[orig_patent_app_number] => 09419587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715434 [patent_doc_number] => 20030026782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'IMMUNOMODULATORY OLIGONUCLEOTIDES' [patent_app_type] => new [patent_app_number] => 09/415142 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11317 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20030026782.pdf [firstpage_image] =>[orig_patent_app_number] => 09415142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411034 [patent_doc_number] => 06524851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Hybrid nucleic acid molecules and vectors including -globin regulatory elements' [patent_app_type] => B1 [patent_app_number] => 09/411449 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 14344 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524851.pdf [firstpage_image] =>[orig_patent_app_number] => 09411449 [rel_patent_id] =>[rel_patent_doc_number] =>)